Search results
Alset Capital Inc. Provides Corporate and Operational Update
Morningstar· 6 days agoNOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES ...
Nvidia CEO, CrowdStrike, Jobs Report Headline Investing Action Plan
Investor's Business Daily· 3 days agoHere's your Investing Action Plan for the week ahead. Nvidia CEO Jensen Huang will make a key speech...
Why Is Arcturus Therapeutics Stock Trading Higher On Tuesday? - Arcturus Therapeutics (NASDAQ:ARCT)
Benzinga· 6 days agoOn Tuesday, Arcturus Therapeutics Holdings Inc. ARCT announced that it will present Phase 1 results in healthy volunteers and new Phase 1b interim data in cystic fibrosis (CF) for ARCT-032 at ...
It's on: our first look at Intel Battlemage comes from Lunar Lake's new graphics silicon with its...
PC Gamer· 4 hours agoBattlemage is coming. At least that's what Intel says at an event dedicated to its new mobile...
Generative AI Sales Could Surge 2,026%: Here's My Pick for the Best AI Stock to Buy Now (Hint: Not...
Motley Fool via Yahoo Finance· 5 days agoAdditionally, Google Cloud customers can customize Gemini with Vertex AI, a machine learning...
Firefly forges on after co-founder murdered by Hamas
TechCrunch· 6 days agoA startup called Firefly that's tackling the thorny and growing issue of cloud asset management with an “infrastructure as code” solution has raised $23...
Weekly softball standings - May 30
The Bismarck Tribune· 5 days agoWEDNESDAY DAKOTA LEAGUE: Bud Light-Turn Two Athletics...
Intel Arrow Lake and AMD Ryzen 9000 motherboards listed from Maxsun — 31 products named, across five...
Tom's Hardware via Yahoo News· 6 days agoIntel and AMD board partner MaxSun has published a huge list of new motherboard model names to the...
Expedia, Kayak, HomeToGo: The AI Travel Race For Booking Platforms
Skift· 5 days agoMany of the travel booking platforms that experimented with generative AI tools early are now...
The Next Humira? Insmed Catapults 119% On Its 'Very Attractive' Opportunity In Lung Disease.
Investor's Business Daily· 6 days agoWilliam Blair analyst Myles Minter noted that the results are encouraging, but questions remain. It...